Kinetoplastids: related protozoan pathogens, different diseases, Journal of Clinical Investigation, vol.118, issue.4, pp.1301-1310, 2008. ,
DOI : 10.1172/JCI33945
Cutaneous leishmaniasis, The Lancet Infectious Diseases, vol.7, issue.9, pp.581-596, 2007. ,
DOI : 10.1016/S1473-3099(07)70209-8
Drug Resistance in Leishmaniasis, Clinical Microbiology Reviews, vol.19, issue.1, pp.111-126, 2006. ,
DOI : 10.1128/CMR.19.1.111-126.2006
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis, Institute Pasteur Kinetoplastid Biol Dis, vol.6, pp.13-15, 2006. ,
Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials, Journal of the American Academy of Dermatology, vol.57, issue.2, pp.335-329, 2007. ,
DOI : 10.1016/j.jaad.2007.01.016
Leishmaniasis vaccine candidates for development: a global overview, Indian J Med Res, vol.123, pp.423-438, 2006. ,
Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis???A meta-analysis, Vaccine, vol.27, issue.35, pp.4747-4753, 2009. ,
DOI : 10.1016/j.vaccine.2009.05.084
Murine cutaneous leishmaniasis : Susceptibility correlates with differential expansion of helper T-cell subsets, Annales de l'Institut Pasteur / Immunologie, vol.138, issue.5, pp.744-749, 1987. ,
DOI : 10.1016/S0769-2625(87)80030-2
The immunology of susceptibility and resistance to leishmania major in mice, Nature Reviews Immunology, vol.2, issue.11, pp.845-858, 2002. ,
DOI : 10.1038/nri933
Comparison of the Immune Profile of Nonhealing Cutaneous Leishmaniasis Patients with Those with Active Lesions and Those Who Have Recovered from Infection, Infection and Immunity, vol.68, issue.4, pp.1760-1764, 2000. ,
DOI : 10.1128/IAI.68.4.1760-1764.2000
Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-?? production, Human Immunology, vol.70, issue.6, pp.383-390, 2009. ,
DOI : 10.1016/j.humimm.2009.01.007
Cytokine Gene Expression in Healing and Non-Healing Cases of Cutaneous Leishmaniasis in Response to In vitro Stimulation with Recombinant gp63 Using Semi-Quantitative RT-PCR, Scandinavian Journal of Immunology, vol.147, issue.4, pp.414-420, 2001. ,
DOI : 10.1016/S0952-7915(96)80040-9
Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG, Clinical and Experimental Immunology, vol.21, issue.2, pp.303-308, 2003. ,
DOI : 10.1016/0022-1759(87)90497-2
Flow cytometric analysis of Leishmania reactive CD4+/CD8+ lymphocyte proliferation in cutaneous leishmaniasis, Iranian J Parasitol, vol.3, pp.9-18, 2008. ,
CD8 cytotoxic T cells in cutaneous leishmaniasis, Parasite Immunology, vol.152, issue.12, pp.671-678, 2007. ,
DOI : 10.1084/jem.174.3.499
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction, Clinical & Experimental Immunology, vol.8, issue.3, pp.500-505, 1993. ,
DOI : 10.1111/j.1365-2249.1993.tb05931.x
T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis, J Clin Microbiol, vol.26, pp.1207-1213, 1988. ,
THE HUMAN CYTOKINE RESPONSE TO LEISHMANIA MAJOR EARLY AFTER EXPOSURE TO THE PARASITE IN VITRO, Journal of Parasitology, vol.90, issue.3, pp.557-563, 2004. ,
DOI : 10.1645/GE-3317
CD8+ T cells are the major lymphocyte subpopulatlon involved in the protective immune response to Toxoplasma gondii in mice, Clinical & Experimental Immunology, vol.138, issue.2, pp.207-212, 1991. ,
DOI : 10.1111/j.1365-2249.1991.tb08150.x
Immunopathogenesis of Cerebral Toxoplasmosis, The Journal of Infectious Diseases, vol.186, issue.s2, pp.234-240, 2002. ,
DOI : 10.1086/344276
Protective and pathogenic roles of CD8+ T cells during malaria infection, Parasite Immunology, vol.173, issue.1-2, pp.15-24, 2006. ,
DOI : 10.1186/1475-2875-2-6
Malaria-Specific and Nonspecific Activation of CD8+ T Cells during Blood Stage of Plasmodium berghei Infection, The Journal of Immunology, vol.181, issue.2, pp.1420-1428, 2008. ,
DOI : 10.4049/jimmunol.181.2.1420
OPINION ??? VACCINES: The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?, Nature Reviews Immunology, vol.71, issue.4, pp.283-291, 2002. ,
DOI : 10.1038/nm1201-1320
Memory CD8+ T cells in HIV infection, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.355, issue.1395, pp.363-367, 2000. ,
DOI : 10.1098/rstb.2000.0575
Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection, PLoS Biology, vol.195, issue.2, p.20, 2004. ,
DOI : 10.1371/journal.pbio.0020020.t001
CD8+ T-Cells: Function and Response to HIV Infection, Current HIV Research, vol.2, issue.1, pp.23-37, 2004. ,
DOI : 10.2174/1570162043485077
T cell responses to Listeria monocytogenes, Current Opinion in Microbiology, vol.7, issue.1, pp.45-50, 2004. ,
DOI : 10.1016/j.mib.2003.12.002
Cross-talk between CD8+ and CD4+ T cells in experimental cutaneous leishmaniasis: CD8+ T cells are required for optimal IFN-gamma production by CD4+ T cells, Parasite Immunology, vol.60, issue.11-12, pp.559-567, 2003. ,
DOI : 10.1146/annurev.immunol.20.100301.064828
Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells, Infect Immun, vol.61, pp.3730-3738, 1993. ,
CD8+ T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis, Parasite Immunology, vol.171, issue.11-12, pp.569-579, 2003. ,
DOI : 10.1084/jem.181.1.387
T Cells, The Journal of Experimental Medicine, vol.162, issue.11, pp.1559-1566, 2004. ,
DOI : 10.1038/nature01152
T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis, Mem??rias do Instituto Oswaldo Cruz, vol.102, issue.5, pp.625-630, 2007. ,
DOI : 10.1590/S0074-02762007005000069
Immunologic patterns associated with cure in human American cutaneous leishmaniasis, Brazilian Journal of Medical and Biological Research, vol.31, issue.1, pp.139-142, 1998. ,
DOI : 10.1590/S0100-879X1998000100019
Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions, British Journal of Dermatology, vol.272, issue.3, pp.537-543, 2005. ,
DOI : 10.1111/j.1365-2133.2005.06647.x
T-Cell-Mediated Immune Responses in Patients with Cutaneous or Mucosal Leishmaniasis: Long-Term Evaluation after Therapy, Clinical and Vaccine Immunology, vol.9, issue.2, pp.251-256, 2002. ,
DOI : 10.1128/CDLI.9.2.251-256.2002
Immune response of BALB/c mice against an experimental vaccine of Alum precipitated autoclaved Leishmania major (Alum-ALM) mixed with BCG or Mycobacterium vaccae, Trop Biomed, vol.27, pp.89-102, 2010. ,
CD4+ T cell subsets in experimental cutaneous leishmaniasis, Mem??rias do Instituto Oswaldo Cruz, vol.83, issue.1, pp.256-259, 1988. ,
DOI : 10.1590/S0074-02761988000500006
Interferon-??- and Tumour Necrosis Factor-??-Producing Cells in Humans who are Immune to Cutaneous Leishmaniasis, Scandinavian Journal of Immunology, vol.62, issue.6, pp.655-659, 1999. ,
DOI : 10.1046/j.1365-3083.1999.00554.x
Parasitological and immunological follow-up of American tegumentary leishmaniasis patients, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.96, issue.1, pp.173-178, 2002. ,
DOI : 10.1016/S0035-9203(02)90072-6
Cellular analysis of cutaneous leishmaniasis lymphadenopathy: insights into the early phases of human disease, Am J Trop Med Hyg, vol.77, pp.854-859, 2007. ,
T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis, Parasite Immunology, vol.63, issue.8, pp.432-439, 2009. ,
DOI : 10.1111/j.1365-3024.2009.01125.x
Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice, Infect Immun, vol.66, pp.3968-3970, 1998. ,
CD8+ T Cells Are Required for Primary Immunity in C57BL/6 Mice Following Low-Dose, Intradermal Challenge with Leishmania major, The Journal of Immunology, vol.168, issue.8, pp.3992-4000, 2002. ,
DOI : 10.4049/jimmunol.168.8.3992
Characterization of the Local and Systemic Immune Responses in Patients with Cutaneous Leishmaniasis Due toLeishmania major, Clinical Immunology, vol.91, issue.3, pp.314-320, 1999. ,
DOI : 10.1006/clim.1999.4705
Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis Patients, Infection and Immunity, vol.70, issue.12, pp.6734-6740, 2002. ,
DOI : 10.1128/IAI.70.12.6734-6740.2002
Flow Cytometric Determination of Cellular Sources and Frequencies of Key Cytokine-Producing Lymphocytes Directed against Recombinant LACK and Soluble Leishmania Antigen in Human Cutaneous Leishmaniasis, Infection and Immunity, vol.69, issue.5, pp.3232-3239, 2001. ,
DOI : 10.1128/IAI.69.5.3232-3239.2001
Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis, Am J Trop Med Hyg, vol.53, pp.273-277, 1995. ,
Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment, Journal of Clinical Laboratory Analysis, vol.420, issue.1, pp.63-69, 2009. ,
DOI : 10.1002/jcla.20291